1.

Record Nr.

UNINA9910158607103321

Autore

Kerner Jeffrey

Titolo

Antipsychotics : History, Science, and Issues / / Jeffrey Kerner, Bridget McCoy M.D

Pubbl/distr/stampa

Westport, CT : , : Greenwood, , 2018

London : , : Bloomsbury Publishing (UK), , 2023

ISBN

9798400613500

9798216048541

9781440839894

1440839891

Edizione

[1st ed.]

Descrizione fisica

1 online resource (xv, 234 pages)

Collana

The Story of a Drug

Disciplina

615.7/882

Soggetti

Psychopharmacology

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Ch. 1: Case Studies -- Ch. 2: What Are Antipsychotics? -- Ch. 3: Antipsychotics: A Brief History -- Ch. 4: How Antipsychotics Work -- Ch. 5: Effects and Applications -- Ch. 6: Risks, Misuse, and Overdose -- Ch. 7: Production, Distribution, and Regulation -- Ch. 8: The Social Dimensions of Antipsychotics -- Ch. 9: The Future of Antipsychotics.

Sommario/riassunto

The problem of serious mental illness is a widely discussed topic in the media and popular culture. This text provides a comprehensive analysis of antipsychotic medications, covering historical, social, and scientific viewpoints on this important and controversial class of medications.  Antipsychotics are unique drugs with the ability to alter how people think and communicate. As a result, physicians must weigh a range of implications when prescribing antipsychotics. Antipsychotics: History, Science, and Issues offers a robust explanation of antipsychotic medications that covers the historical, ethical, medical, legal, and scientific dimensions of antipsychotics.   The chapters explore topics ranging from the science of how examples of this class of drug actually work in the body to the social and legal implications of antipsychotics, making this subject understandable and relatable for lay readers who are not mental health practitioners. Readers will learn why prescribing



antipsychotics is often a difficult decision due to the inherent risks of giving these medications to different types of patients and appreciate how mental health laws impact psychiatrists' prescribing practices.